索拉费尼布加上类似记忆的自然杀手细胞免疫化学疗法,可以提高肝癌治疗反应
Aydin Eresen1, Zigeng Zhang1, Guangbo Yu2
1Department of Radiological Sciences, University of California Irvine, Irvine, CA, USA.
BMC cancer
|September 30, 2024
概括
将sorafenib与工程化类似记忆的自然杀手 (NK) 细胞相结合,显著增强了肝细胞癌治疗. 这种新型免疫化学疗法在临床前模型中显示出优异的瘤回归和增加NK细胞透.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物开发 药物开发
背景情况:
- 肝细胞癌 (HCC) 的异质性带来了治疗挑战.
- 需要结合的方法来克服瘤微环境的抑制作用.
- 细胞因子诱导的类似记忆的自然杀手 (NK) 细胞为增强抗瘤免疫提供了一个有希望的策略.
研究的目的:
- 为了研究将索拉芬尼与工程记忆样NK (pNK) 细胞结合用于HCC治疗的疗效.
- 评估这种组合免疫化疗对瘤生长和瘤微环境在临床前HCC模型中的影响.
主要方法:
- 在SD大鼠中确立了肝细胞癌 (HCC) 瘤.
- 自然杀手 (NK) 细胞被设计成具有类似于记忆的特性,使用了Interleukin 12/18细胞因子.
- 携带瘤的老鼠接受了对照剂,PNK免疫疗法,索拉芬尼或组合疗法,并通过多参数核磁共振和组织病理学监测治疗反应.
主要成果:
- 与单一疗法相比,组合疗法导致了最显著的瘤回归.
- 组织学分析显示,结合组中瘤细胞破坏 (63.79%) 和NK细胞透率增加 (34.79%).
- 虽然索拉费尼布单一治疗减少了可行的瘤区域,但PNK免疫治疗显示出比单独索拉费尼布更强的组织学反应.
结论:
- 组合疗法显著提高了HCC的治疗反应.
- 开发的pNK细胞免疫化学疗法与索拉芬尼结合,为大幅减少瘤生长提供了强有力的策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
06:55Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
18.5K
相关概念视频
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857
